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Résumé en
anglais
Interleukin-26 (IL-26), a member of the IL-10 cytokine family, induces the production
of proinflammatory cytokines by epithelial cells. IL-26 has been also reported
overexpressed in Crohn's disease, suggesting that it may be involved in the
physiopathology of chronic inflammatory disorders. Here, we have analyzed the
expression and role of IL-26 in rheumatoid arthritis (RA), a chronic inflammatory
disorder characterized by joint synovial inflammation. We report that the
concentrations of IL-26 are higher in the serums of RA patients than of healthy
subjects and dramatically elevated in RA synovial fluids compared to RA serums.
Immunohistochemistry reveals that synoviolin+ fibroblast-like synoviocytes and
CD68+ macrophage-like synoviocytes are the main IL-26-producing cells in RA joints.
Fibroblast-like synoviocytes from RA patients constitutively produce IL-26 and this
production is upregulated by IL-1-beta and IL-17A. We have therefore investigated
the role of IL-26 in the inflammatory process. Results show that IL-26 induces the
production of the proinflammatory cytokines IL-1-beta, IL-6, and tumor necrosis
factor (TNF)-alpha by human monocytes and also upregulates the expression of
numerous chemokines (mainly CCL20). Interestingly, IL-26-stimulated monocytes
selectively promote the generation of RORgamma t+ Th17 cells, through IL-1-beta
secretion by monocytes. More precisely, IL-26-stimulated monocytes switch non-
Th17 committed (IL-23R− or CCR6− CD161−) CD4+ memory T cells into Th17 cells.
Finally, synovial fluids from RA patients also induce Th17 cell generation and this
effect is reduced after IL-26 depletion. These findings show that IL-26 is
constitutively produced by RA synoviocytes, induces proinflammatory cytokine
secretion by myeloid cells, and favors Th17 cell generation. IL-26 thereby appears as
a novel proinflammatory cytokine, located upstream of the proinflammatory cascade,
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